Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines.
about
T cell homeostatic proliferation elicits effective antitumor autoimmunityDEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypesCD8+ T lymphocyte responses target functionally important regions of Protease and Integrase in HIV-1 infected subjectsDendritic Cells in Oncolytic Virus-Based Anti-Cancer TherapyLymphoma Immunotherapy: Current StatusChloroquine enhances human CD8+ T cell responses against soluble antigens in vivoAntigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cellsMHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cellsViral sequestration of antigen subverts cross presentation to CD8(+) T cells.Restricting expression prolongs expression of foreign genes introduced into animals by retroviruses.CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.Induction of anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) and CD4(+) T-cell reactivity by dendritic cells loaded with HIV-1 X4-infected apoptotic cells.Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 GT cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein.A polymeric protein induces specific cytotoxicity in a TLR4 dependent manner in the absence of adjuvants.Cell-extrinsic effects of tumor ER stress imprint myeloid dendritic cells and impair CD8⁺ T cell priming.Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor.Heat-aggregated noninfectious influenza virus induces a more balanced CD8(+)-T-lymphocyte immunodominance hierarchy than infectious virusA macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgelsThe role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells.Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells.Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.Induction of primary anti-HIV CD4 and CD8 T cell responses by dendritic cells transduced with self-inactivating lentiviral vectors.Independence of measles-specific humoral and cellular immune responses to vaccinationStructure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles.Combining radiotherapy and immunotherapy: a revived partnership.Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cellsPresentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation.Trafficking of spontaneously endocytosed MHC proteins.Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.DC-based cancer vaccines.Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell primingT cell immunity using transgenic B lymphocytes.Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.The amino acid sequences flanking an antigenic determinant can strongly affect MHC class I cross-presentation without altering direct presentation.Mechanism of cellular rejection in transplantationEstablishment of tumor-associated immunity requires interaction of heat shock proteins with CD91.Endogenous and tumour-derived microRNAs regulate cross-presentation in dendritic cells and consequently cytotoxic T cell function.A novel trafficking signal within the HLA-C cytoplasmic tail allows regulated expression upon differentiation of macrophages.Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis.
P2860
Q24553060-748B7DDB-8444-4263-9884-2D0589921F82Q24682603-C3896C97-C2B3-4A20-A2E3-FBF76BC0FC9FQ24798701-DBF904A5-5AB2-4A89-A510-6AE1830D461BQ26774345-292893E3-28DE-4E69-AF88-13BD764D2499Q26782902-A2869680-6728-45C4-958B-1D6BC351C3FEQ27485211-3DCF5F2F-EF95-47E3-9374-EE2C230BEA8CQ28348352-900F5533-DF1B-4F00-8BB6-0411FBB75781Q28473636-2C060979-539E-4327-99CB-160DE56293F0Q33455511-FFD681D6-6EBA-4AEC-866C-1BAB113AF591Q33603763-236441A4-FEBE-4532-98A8-883A963DE199Q33928441-45B1214F-CDDF-4707-896E-6D29C8AD1053Q34332462-535047DF-D049-45D6-A109-D388F420A90EQ34342982-6B973924-125A-4763-8AEE-931B3D342A14Q34416263-2EB2FEE9-FB42-4A15-A08B-44861BD362BFQ34429859-9A83FA6F-B4F5-45CC-A36F-D56C9989B311Q34525738-5B98203D-A0A4-48BF-9837-7B2C8A424CF8Q34833647-5EF45305-53BD-44E5-8997-F7E0A845CFCAQ34858946-47F5090D-4232-4732-95C0-678A351EE9BEQ34981649-225967B9-7754-4972-8BCA-CD8708B9F1D1Q34982772-DB7461BA-5E12-4608-B849-1583BA87B226Q35049453-4E82126D-FD55-485A-A322-3BB73E717C21Q35234948-F8724592-FED0-44FE-9F44-737B17A8BC61Q35751773-22915D42-2ADD-4DD0-BC45-3062532065ADQ35918575-A65A26EE-0E08-4FCB-996C-36B4ECB63C43Q36010016-41A8F452-48CE-4C21-BCD5-124BBDD6C49BQ36274581-A1FE0043-553E-4E59-9064-A309F9A688BCQ36371928-E0110AF5-9049-4A03-B302-5D65EBDF7AEFQ36376648-3B985562-3BA4-4A12-878A-E35A9D81D9C5Q36703975-82208F62-4CB1-4BA8-9151-712A5D694301Q36791009-C38E21E7-330A-4A08-B64D-6284C1F2C4E1Q36809780-EBB6C630-AE2B-4A14-9B8D-4B7E6277BDF7Q37089414-D53DD319-5DAA-4AB5-A403-742C80C5A16AQ37095167-F54900EF-A0E3-45D5-BCD0-28DA8202C341Q37109545-98918DE0-1E8D-4355-BE94-4F452E06EECEQ37372907-C50BE0A7-07E5-4DE2-9B32-5775936D23D7Q37424651-236D1CE3-C849-4865-BCA1-85A9F82FEE88Q37732973-521DF1F2-1F4D-40E7-886E-4F2A57F2A516Q38837651-E3F01A80-CB41-433B-BAD7-6692CE8316D5Q39603042-08F325EE-CCDB-44D1-9869-262B50BD2A4AQ39605166-E12A0BE9-3212-46F2-8D86-C4E26442F517
P2860
Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mechanisms of exogenous antige ...... rs, transplants, and vaccines.
@ast
Mechanisms of exogenous antige ...... rs, transplants, and vaccines.
@en
type
label
Mechanisms of exogenous antige ...... rs, transplants, and vaccines.
@ast
Mechanisms of exogenous antige ...... rs, transplants, and vaccines.
@en
prefLabel
Mechanisms of exogenous antige ...... rs, transplants, and vaccines.
@ast
Mechanisms of exogenous antige ...... rs, transplants, and vaccines.
@en
P2093
P1476
Mechanisms of exogenous antige ...... rs, transplants, and vaccines.
@en
P2093
Bennink JR
Norbury CC
Yewdell JW
P577
1999-01-01T00:00:00Z